ARK Investment Management Discloses 21.2M Teladoc Shares
Ticker: TDOC · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 1477449
| Field | Detail |
|---|---|
| Company | Teladoc Health, Inc. (TDOC) |
| Form Type | SC 13G/A |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, healthcare-tech
Related Tickers: TDOC
TL;DR
**ARK still holds over 21 million shares of Teladoc, signaling continued conviction.**
AI Summary
ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on January 29, 2024, disclosing its ownership of Teladoc Health, Inc. common stock as of December 31, 2023. The filing shows ARK beneficially owns 21,224,565 shares, representing a significant stake in the virtual healthcare provider. This matters to investors because ARK is a prominent institutional investor known for its high-conviction growth stock picks, and its continued large holding could signal confidence in Teladoc's long-term prospects, or conversely, any future reduction could indicate a shift in their investment thesis.
Why It Matters
This filing confirms ARK Investment Management's substantial stake in Teladoc Health, providing transparency into a major institutional investor's position and potentially influencing market sentiment.
Risk Assessment
Risk Level: low — This is a routine amendment filing by an institutional investor, not indicating any immediate negative or positive event for the company.
Analyst Insight
Investors should note ARK's continued large position in Teladoc, but also monitor future filings for any significant changes, as ARK's investment decisions can influence market perception of growth stocks.
Key Numbers
- 21,224,565 — Total Shares Beneficially Owned (This is the total number of Teladoc Health, Inc. common stock shares ARK Investment Management LLC reported owning as of December 31, 2023.)
- 20,164,041 — Sole Voting Power Shares (This represents the number of shares over which ARK Investment Management LLC has exclusive voting control.)
- 535,392 — Shared Voting Power Shares (This indicates the number of shares over which ARK Investment Management LLC shares voting control with other entities.)
- 21,224,565 — Sole Dispositive Power Shares (This is the number of shares over which ARK Investment Management LLC has exclusive power to sell or dispose of.)
Key Players & Entities
- ARK Investment Management LLC (company) — the reporting person and institutional investor
- Teladoc Health, Inc. (company) — the subject company whose shares are being reported
- Delaware (company) — place of organization for ARK Investment Management LLC
- 21,224,565 (dollar_amount) — total shares beneficially owned by ARK Investment Management LLC
- December 31, 2023 (date) — date of the event requiring the filing
Forward-Looking Statements
- ARK Investment Management will maintain a significant stake in Teladoc Health, Inc. throughout 2024. (ARK Investment Management LLC) — medium confidence, target: 2024-12-31
FAQ
What is the purpose of this SC 13G/A filing?
This SC 13G/A filing is an amendment (Amendment No. 3) to a Schedule 13G, filed by ARK Investment Management LLC, to update its beneficial ownership of Teladoc Health, Inc. common stock as of December 31, 2023, under Rule 13d-1(b).
Who is the reporting person in this filing and what company's shares are they reporting?
The reporting person is ARK Investment Management LLC, and they are reporting their beneficial ownership of common stock in Teladoc Health, Inc.
How many shares of Teladoc Health, Inc. did ARK Investment Management LLC beneficially own as of the reporting date?
As of December 31, 2023, ARK Investment Management LLC beneficially owned a total of 21,224,565 shares of Teladoc Health, Inc. common stock.
What is the breakdown of voting power for the shares reported by ARK Investment Management LLC?
ARK Investment Management LLC reported having sole voting power over 20,164,041 shares and shared voting power over 535,392 shares of Teladoc Health, Inc.
What is the CUSIP number for Teladoc Health, Inc. common stock mentioned in the filing?
The CUSIP number for Teladoc Health, Inc. common stock, as stated in the filing, is 87918A105.
Filing Stats: 941 words · 4 min read · ~3 pages · Grade level 7.7 · Accepted 2024-01-29 16:01:01
Filing Documents
- tm244117d24_sc13ga.htm (SC 13G/A) — 44KB
- 0001104659-24-007695.txt ( ) — 46KB
(a) Name of issuer
Item 1(a) Name of issuer: Teladoc Health, Inc.
(b) Address of issuer's principal executive offices
Item 1(b) Address of issuer's principal executive offices: 2 Manhattanville Road, Suite 203, Purchase, New York 10577
(a) Name of person filing
Item 2(a) Name of person filing: ARK Investment Management LLC
(b) Address or principal business office or, if none,
Item 2(b) Address or principal business office or, if none, residence: ARK Investment Management LLC 200 Central Avenue St. Petersburg, FL 33701
(c) Citizenship
Item 2(c) Citizenship: Delaware, United States
(d) Title of class of securities
Item 2(d) Title of class of securities: Common stock
(e) CUSIP No
Item 2(e) CUSIP No.: 87918A105
If this statement is filed pursuant to §§ 240.13d-1(b) or
Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ CUSIP No. 87918A105 13G Page 4 of 5 Pages
Ownership
Item 4. Ownership (a) Amount beneficially owned: 21,224,565 (b) Percent of class: 12.82% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 20,164,041 (ii) Shared power to vote or to direct the vote: 535,392 (iii) Sole power to dispose or to direct the disposition of: 21,224,565 (iv) Shared power to dispose or to direct the disposition of: 0
Ownership of 5 Percent or Less of a Class
Item 5. Ownership of 5 Percent or Less of a Class. Not applicable. Item 6. Ownership of More than 5 Percent on Behalf of Another Person. To the knowledge of the Reporting Person, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, a number of the shares which represents more than five percent of the number of outstanding class of the shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. CUSIP No. 87918A105 13G Page 5 of 5 Pages Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. The reporting persons agree that this statement is filed on behalf of each of them. Dated: January 29, 2024 ARK Investment Management LLC By: /s/ Kellen Carter Name: Kellen Carter Title: Chief Compliance Officer